Wells Fargo analyst David Maris noted that Bausch Health (BHC) acquired Johnson & Johnson’s (JNJ) Shower to Shower body powder in 2012 and has subsequently been named as a defendant in more than 160 lawsuits. Bausch Health stated in a recent filing that “While Johnson & Johnson continues to indemnify the Company, the Company has initiated proceedings in arbitration against Johnson & Johnson relating to the scope and amount of such indemnification,” Maris noted. He contends that if Bausch is going to arbitration with J&J to clarify the extent of indemnification, it should be considered a risk investors consider that the companies come to different conclusions as to this indemnification. Maris maintains an Underperform rating on Bausch Health shares.